181 related articles for article (PubMed ID: 37249796)
81. A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma.
Arabadzhieva E; Yonkov A; Bonev S; Bulanov D; Taneva I; Vlahova A; Dikov T; Dimitrova V
World J Surg Oncol; 2016 Nov; 14(1):287. PubMed ID: 27846844
[TBL] [Abstract][Full Text] [Related]
82. Pancreatoblastoma in an elderly woman: A case report simulating a pancreatic neuroendocrine tumour with emphasis on cytomorphological features.
Saoud C; Wu AA; Fishman EK; Hruban RH; Ali SZ
Cytopathology; 2023 May; 34(3):254-258. PubMed ID: 36546760
[TBL] [Abstract][Full Text] [Related]
83. Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome.
Metovic J; Cascardi E; Uccella S; Maragliano R; Querzoli G; Osella-Abate S; Pittaro A; La Rosa S; Bogina G; Cassoni P; Marchiò C; Sapino A; Castellano I; Papotti M
Virchows Arch; 2022 Dec; 481(6):839-846. PubMed ID: 36243799
[TBL] [Abstract][Full Text] [Related]
84. Acinar cell carcinoma of gastric ectopic pancreas origin: a case report and literature review.
Chen Y; Zhou N; Guo D; He X; Tang H; Wang L; Xu Y; Xu T
Diagn Pathol; 2023 Mar; 18(1):37. PubMed ID: 36927376
[TBL] [Abstract][Full Text] [Related]
85. Gastric carcinosarcoma with neuroendocrine differentiation as the carcinoma component and leiomyosarcomatous and myofibroblastic differentiation as the sarcomatous component.
Kuroda N; Oonishi K; Iwamura S; Ohara M; Hirouchi T; Mizumo K; Miyazaki E; Enzan H
APMIS; 2006 Mar; 114(3):234-8. PubMed ID: 16643190
[TBL] [Abstract][Full Text] [Related]
86. Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours.
Kim JY; Brosnan-Cashman JA; Kim J; An S; Lee KB; Kim H; Park DY; Jang KT; Oh YH; Hruban RH; Heaphy CM; Hong SM
Pathology; 2020 Apr; 52(3):336-347. PubMed ID: 32111396
[TBL] [Abstract][Full Text] [Related]
87. Amphicrine gastric carcinoma.
Reis-Filho JS; Schmitt FC
Arch Pathol Lab Med; 2001 Nov; 125(11):1513-4. PubMed ID: 11698020
[No Abstract] [Full Text] [Related]
88. Hepatoid carcinoma of the pancreas penetrating into the gastric cavity: a case report and literature review.
Kai K; Nakamura J; Ide T; Masuda M; Kitahara K; Miyoshi A; Noshiro H; Tokunaga O
Pathol Int; 2012 Jul; 62(7):485-90. PubMed ID: 22726068
[TBL] [Abstract][Full Text] [Related]
89. Metastatic mixed acinar-neuroendocrine carcinoma of the pancreas to the liver: a cytopathology case report with review of the literature.
Lee L; Bajor-Dattilo EB; Das K
Diagn Cytopathol; 2013 Feb; 41(2):164-70. PubMed ID: 22903971
[TBL] [Abstract][Full Text] [Related]
90. Subcutaneous fat necrosis as the presenting feature of a pancreatic carcinoma: the challenge of differentiating endocrine and acinar pancreatic neoplasms.
Martin SK; Agarwal G; Lynch GR
Pancreas; 2009 Mar; 38(2):219-22. PubMed ID: 19238022
[TBL] [Abstract][Full Text] [Related]
91. Amphicrine Medullary Thyroid Carcinoma - a Case-Based Review Expanding on Its MUC Expression Profile.
Khandakar H; Agarwal S; Sharma MC; Kandasamy D; Bal C; Rathode Y; Aphale R
Endocr Pathol; 2022 Sep; 33(3):378-387. PubMed ID: 35733030
[TBL] [Abstract][Full Text] [Related]
92. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
93. Pulmonary Carcinomas With Mucinous and Neuroendocrine Differentiation: Expanding the Spectrum of Amphicrine Carcinomas.
Weissferdt A
Am J Surg Pathol; 2018 Sep; 42(9):1246-1252. PubMed ID: 30001241
[TBL] [Abstract][Full Text] [Related]
94. Genetic basis of a common tumor origin in the development of pancreatic mixed acinar-neuroendocrine-ductal carcinoma: A case report.
Takano A; Hirotsu Y; Amemiya K; Nakagomi H; Oishi N; Oyama T; Mochizuki H; Omata M
Oncol Lett; 2017 Oct; 14(4):4428-4432. PubMed ID: 29085438
[TBL] [Abstract][Full Text] [Related]
95. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.
Tanigawa M; Nakayama M; Taira T; Hattori S; Mihara Y; Kondo R; Kusano H; Nakamura K; Abe Y; Ishida Y; Okabe Y; Hisaka T; Okuda K; Fujino K; Ito T; Kawahara A; Naito Y; Yamaguchi R; Akiba J; Akagi Y; Yano H
Med Mol Morphol; 2018 Mar; 51(1):32-40. PubMed ID: 28849340
[TBL] [Abstract][Full Text] [Related]
96. Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.
Lam AK; Ishida H
Histol Histopathol; 2021 Apr; 36(4):367-382. PubMed ID: 33305819
[TBL] [Abstract][Full Text] [Related]
97. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
[TBL] [Abstract][Full Text] [Related]
98. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.
Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I
World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209
[TBL] [Abstract][Full Text] [Related]
99. Pathogenic ATM Variant-Harbouring Well-Differentiated Aggressive Type 1 Gastric Neuroendocrine Tumour with High-grade Features (G3 NET): a New Addition to the Clinical and Pathological Spectrum of Gastric Neuroendocrine Neoplasms.
Nassereddine H; Chicaud M; Rebah K; Théou-Anton N; Sautet A; Dermer J; Couvelard A
Endocr Pathol; 2021 Dec; 32(4):517-523. PubMed ID: 34019237
[TBL] [Abstract][Full Text] [Related]
100. Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation.
Speck O; Tang W; Morgan DR; Kuan PF; Meyers MO; Dominguez RL; Martinez E; Gulley ML
Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):633-45. PubMed ID: 25517873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
